X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (19) 19
humans (18) 18
cancer (16) 16
index medicus (16) 16
female (14) 14
prognosis (13) 13
aged (12) 12
middle aged (12) 12
male (11) 11
care and treatment (9) 9
chemotherapy (9) 9
[ sdv.can ] life sciences [q-bio]/cancer (8) 8
adult (8) 8
life sciences (8) 8
aged, 80 and over (7) 7
breast cancer (7) 7
medicine & public health (7) 7
metastasis (7) 7
radiology, nuclear medicine & medical imaging (6) 6
research (6) 6
retrospective studies (6) 6
analysis (5) 5
carcinoma (5) 5
medicine (5) 5
prostate cancer (5) 5
radiotherapy (5) 5
research article (5) 5
risk factors (5) 5
surgery (5) 5
tumors (5) 5
[sdv.can]life sciences [q-bio]/cancer (4) 4
adjuvant chemotherapy (4) 4
adolescent (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
biomarkers (4) 4
biomarkers, tumor - metabolism (4) 4
cancer therapies (4) 4
clinical trials (4) 4
combined modality therapy (4) 4
health aspects (4) 4
medical prognosis (4) 4
medical research (4) 4
nuclear medicine (4) 4
survival (4) 4
survival rate (4) 4
treatment outcome (4) 4
young adult (4) 4
biomarkers, tumor - genetics (3) 3
breast neoplasms - drug therapy (3) 3
breast neoplasms - pathology (3) 3
chemotherapy, adjuvant (3) 3
child (3) 3
diagnosis (3) 3
follow-up studies (3) 3
gene expression profiling (3) 3
kaplan-meier estimate (3) 3
management (3) 3
neoplasm staging (3) 3
osteosarcoma - drug therapy (3) 3
patients (3) 3
progression (3) 3
quality of life (3) 3
radiation therapy (3) 3
radioimmunotherapy (3) 3
randomized-trial (3) 3
survival analysis (3) 3
therapy (3) 3
toxicity (3) 3
trial (3) 3
usage (3) 3
aged patients (2) 2
animals (2) 2
antibodies, bispecific - therapeutic use (2) 2
antineoplastic agents - therapeutic use (2) 2
biology and life sciences (2) 2
bispecific antibody (2) 2
bone neoplasms - drug therapy (2) 2
breast neoplasms - genetics (2) 2
breast neoplasms - mortality (2) 2
breast neoplasms - surgery (2) 2
cancer patients (2) 2
cancers and neoplasms (2) 2
carcinoembryonic antigen (2) 2
carcinoembryonic antigen - immunology (2) 2
cardiology (2) 2
case-control studies (2) 2
cea (2) 2
cisplatin (2) 2
clinicogenomic model (2) 2
cohort studies (2) 2
complications and side effects (2) 2
dose hypofractionation (2) 2
doubling time (2) 2
expression (2) 2
fec100 regimen (2) 2
gene expression (2) 2
gene-expression (2) 2
gene-expression profiles (2) 2
genetic aspects (2) 2
genomic study (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 96, Issue 4, pp. 840 - 847
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 5/2010, Volume 97, Issue 3, pp. 311 - 322
Journal Article
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 1/2018, Volume 26, Issue 1, pp. 81 - 89
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 44, pp. 77050 - 77060
Purpose: The aim of this retrospective study was to determine, at baseline, the prognostic value of different FDG-PET/CT quantitative parameters in a... 
Ewing sarcoma family of tumors | FDG-PET/CT | Survival analysis | Oncology | Prognosis | METAANALYSIS | PROGNOSTIC-FACTORS | prognosis | IFOSFAMIDE | CANCER | oncology | CHEMOTHERAPY | DIAGNOSTIC-ACCURACY | CELL BIOLOGY | TRIAL | F-18-FDG PET | ETOPOSIDE | POSITRON-EMISSION-TOMOGRAPHY | survival analysis | ewing sarcoma family of tumors | Life Sciences | Cancer
Journal Article
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 08/2012, Volume 53, Issue 8, pp. 1185 - 1192
The prognosis of medullary thyroid carcinoma (MTC) varies from long- to short-term survival based on such prognostic factors as serum calcitonin and... 
Doubling time | Bispecific antibody | CEA | Medullary thyroid carcinoma | Radioimmunotherapy | radioimmunotherapy | doubling time | CLINICAL-TRIAL | EFFICACY | LOCK METHOD | TOXICITY | KINASE INHIBITOR | PEPTIDE | BIVALENT HAPTEN | POSITRON-EMISSION-TOMOGRAPHY | bispecific antibody | CANCER XENOGRAFT | medullary thyroid carcinoma | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Humans | Middle Aged | Male | Pentetic Acid - immunology | Young Adult | Neoplasm Metastasis | Aged, 80 and over | Biomarkers, Tumor - metabolism | Radioimmunotherapy - methods | Adult | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoembryonic Antigen - immunology | Treatment Outcome | Thyroid Neoplasms - radiotherapy | Disease Progression | Antibodies, Bispecific - therapeutic use | Animals | Antibodies, Bispecific - adverse effects | Carcinoma, Neuroendocrine | Survival Analysis | Aged | Mice | Radioimmunotherapy - adverse effects | Thyroid Neoplasms - metabolism | Thyroid Neoplasms - pathology | Confidence intervals | Thyroid cancer | Disease | Medical treatment | Bone marrow | Clinical trials | Biomarkers | Indium | Cancer therapies | Cancer | Thyroid Neoplasms | Tumor Markers, Biological | Pentetic Acid | Life Sciences | Antibodies, Monoclonal, Humanized | Antibodies, Bispecific | Carcinoembryonic Antigen
Journal Article
Frontiers in Medicine, ISSN 2296-858X, 2015, Volume 2, p. 46
The aim of this retrospective study was to evaluate the contribution of fluorine-18-fluoro-deoxyglucose (FDG) positron emission tomography (PET) to the... 
Recurrence | 18F-FDG | Survival outcome | PET/CT | Ovarian cancer | Care and treatment | Patient outcomes | Medical care | Research | Management | Diagnosis | Life Sciences | Cancer | ovarian cancer
Journal Article
Journal Article
Radiation Oncology, ISSN 1748-717X, 08/2015, Volume 10, Issue 1, pp. 161 - 161
Journal Article
Journal Article